SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis.

Smith, ER; Oakley, E; Grandner, GW; Ferguson, K; Farooq, F; Afshar, Y; Ahlberg, M; Ahmadzia, H; Akelo, V; Aldrovandi, G; et al. Smith, ER; Oakley, E; Grandner, GW; Ferguson, K; Farooq, F; Afshar, Y; Ahlberg, M; Ahmadzia, H; Akelo, V; Aldrovandi, G; Tippett Barr, BA; Bevilacqua, E; Brandt, JS; Broutet, N; Fernández Buhigas, I; Carrillo, J; Clifton, R; Conry, J; Cosmi, E; Crispi, F; Crovetto, F; Delgado-López, C; Divakar, H; Driscoll, AJ; Favre, G; Flaherman, VJ; Gale, C; Gil, MM; Gottlieb, SL; Gratacós, E; Hernandez, O; Jones, S; Kalafat, E; Khagayi, S; Knight, M; Kotloff, K; Lanzone, A; Le Doare, K; Lees, C; Litman, E; Lokken, EM; Laurita Longo, V; Madhi, SA; Magee, LA; Martinez-Portilla, RJ; McClure, EM; Metz, TD; Miller, ES; Money, D; Moungmaithong, S; Mullins, E; Nachega, JB; Nunes, MC; Onyango, D; Panchaud, A; Poon, LC; Raiten, D; Regan, L; Rukundo, G; Sahota, D; Sakowicz, A; Sanin-Blair, J; Söderling, J; Stephansson, O; Temmerman, M; Thorson, A; Tolosa, JE; Townson, J; Valencia-Prado, M; Visentin, S; von Dadelszen, P; Adams Waldorf, K; Whitehead, C; Yassa, M; Tielsch, JM; Perinatal COVID PMA Study Collaborators; Perinatal COVID PMA Study Collaborators (2023) Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob Health, 8 (1). e009495. ISSN 2059-7908 https://doi.org/10.1136/bmjgh-2022-009495
SGUL Authors: Le Doare, Kirsty

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

INTRODUCTION: Despite a growing body of research on the risks of SARS-CoV-2 infection during pregnancy, there is continued controversy given heterogeneity in the quality and design of published studies. METHODS: We screened ongoing studies in our sequential, prospective meta-analysis. We pooled individual participant data to estimate the absolute and relative risk (RR) of adverse outcomes among pregnant women with SARS-CoV-2 infection, compared with confirmed negative pregnancies. We evaluated the risk of bias using a modified Newcastle-Ottawa Scale. RESULTS: We screened 137 studies and included 12 studies in 12 countries involving 13 136 pregnant women.Pregnant women with SARS-CoV-2 infection-as compared with uninfected pregnant women-were at significantly increased risk of maternal mortality (10 studies; n=1490; RR 7.68, 95% CI 1.70 to 34.61); admission to intensive care unit (8 studies; n=6660; RR 3.81, 95% CI 2.03 to 7.17); receiving mechanical ventilation (7 studies; n=4887; RR 15.23, 95% CI 4.32 to 53.71); receiving any critical care (7 studies; n=4735; RR 5.48, 95% CI 2.57 to 11.72); and being diagnosed with pneumonia (6 studies; n=4573; RR 23.46, 95% CI 3.03 to 181.39) and thromboembolic disease (8 studies; n=5146; RR 5.50, 95% CI 1.12 to 27.12).Neonates born to women with SARS-CoV-2 infection were more likely to be admitted to a neonatal care unit after birth (7 studies; n=7637; RR 1.86, 95% CI 1.12 to 3.08); be born preterm (7 studies; n=6233; RR 1.71, 95% CI 1.28 to 2.29) or moderately preterm (7 studies; n=6071; RR 2.92, 95% CI 1.88 to 4.54); and to be born low birth weight (12 studies; n=11 930; RR 1.19, 95% CI 1.02 to 1.40). Infection was not linked to stillbirth. Studies were generally at low or moderate risk of bias. CONCLUSIONS: This analysis indicates that SARS-CoV-2 infection at any time during pregnancy increases the risk of maternal death, severe maternal morbidities and neonatal morbidity, but not stillbirth or intrauterine growth restriction. As more data become available, we will update these findings per the published protocol.

Item Type: Article
Additional Information: © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Keywords: COVID-19, Epidemiology, Maternal health, Infant, Newborn, Pregnancy, Female, Humans, Pregnant Women, Prospective Studies, COVID-19, SARS-CoV-2, Perinatal COVID PMA Study Collaborators, Perinatal COVID PMA Study Collaborators, Humans, Prospective Studies, Pregnancy, Infant, Newborn, Pregnant Women, Female, COVID-19, SARS-CoV-2, COVID-19, Maternal health, Epidemiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: BMJ Glob Health
ISSN: 2059-7908
Language: eng
Dates:
DateEvent
16 January 2023Published
24 August 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
001World Health OrganizationUNSPECIFIED
INV-022057Bill and Melinda Gates Foundationhttp://dx.doi.org/10.13039/100000865
PubMed ID: 36646475
Web of Science ID: WOS:000926228300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115321
Publisher's version: https://doi.org/10.1136/bmjgh-2022-009495

Actions (login required)

Edit Item Edit Item